Regen BioPharma, Inc.: Revision history

20 August 2022

• curprev 15:1815:18, 20 August 2022 95.149.241.133 talk 493 bytes +11 No edit summary undo

13 August 2022

• curprev 23:1323:13, 13 August 2022 109.180.50.163 talk 482 bytes +15 No edit summary undo

31 July 2022

• curprev 00:2300:23, 31 July 2022 >Chris 467 bytes +467 Created page with "Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California."